Two Nature studies: MIRA and AMIE match or surpass doctors in diagnosis and treatment planning
Original title:AI systems rival doctors in new Nature studies, but one result suggests the tech won't age well
AI summary
The MIRA agent developed by a German team operates 85,000 options in simulated electronic medical records, achieving 88.9% diagnostic accuracy in more than 500 emergency cases; in a comparison test (311 cases) it scored 87.8%, higher than senior specialists (78.1%) and mixed teams (71.1%). MIRA performed best on appendicitis (98.6%) and pancreatitis (92.3%), with no dangerous drug interactions or dosage errors found, performance unaffected by language, and its code made public. Google's AMIE uses a dual-agent architecture, achieving 95% treatment plan appropriateness in 100 multi-visit cases (72% for primary care physicians) and surpassing doctors on the RxQA drug knowledge benchmark. Both studies warn of gaps between simulated environments and reality, with real-world performance possibly lower.
Key Takeaways
- The MIRA agent developed by a German team operates 85,000 options in simulated electronic medical…
- 9% diagnostic accuracy in more than 500 emergency cases
- in a comparison test (311 cases) it scored 87.
- 8%,higher than senior specialists (78.
- 1%) and mixed teams (71.
Quick Facts
- Published
- Updated
- Source
- The Decoder:AI News(RSS)
- Category
- Papers & Research
- AI score
- 78
两项 Nature 研究把 AI 诊断推到了和医生掰手腕的水平,但更值得关注的是那个被埋起来的实验:更强的模型一上来,精心搭建的 double-agent 架构几乎归零。医疗 AI 的护城河可能不是架构而是接入院内系统的能力。
Related entities
Source & copyright
This article is based on curated titles and AI summaries from the AIHOT public API, with attribution and links back. Original copyright remains with the original publishers and authors; this site does not mirror full texts.
How to Cite
When citing this article, keep the title, date, and permalink, and credit Orange News as the source.
Orange News: Two Nature studies: MIRA and AMIE match or surpass doctors in diagnosis and treatment planning. June 18, 2026. https://new.nat6.net/en/news/cmqjmc80604sqslmhz4738b0k/